• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ranolazine - could an antianginal drug be used in stroke prevention?

作者信息

Surma Stanisław, Romańczyk Monika, Filipiak Krzysztof J

机构信息

Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

Club of Young Hypertensiologists, Polish Society of Hypertension, Gdańsk, Poland.

出版信息

Int J Cardiol Cardiovasc Risk Prev. 2022 May 30;14:200137. doi: 10.1016/j.ijcrp.2022.200137. eCollection 2022 Sep.

DOI:10.1016/j.ijcrp.2022.200137
PMID:35677351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9168496/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b423/9168496/bf951b246316/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b423/9168496/bf951b246316/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b423/9168496/bf951b246316/gr1.jpg

相似文献

1
Ranolazine - could an antianginal drug be used in stroke prevention?雷诺嗪——一种抗心绞痛药物能用于预防中风吗？
Int J Cardiol Cardiovasc Risk Prev. 2022 May 30;14:200137. doi: 10.1016/j.ijcrp.2022.200137. eCollection 2022 Sep.
2
Spotlight on ranolazine in chronic stable angina pectoris.慢性稳定型心绞痛中雷诺嗪的聚焦报道
Am J Cardiovasc Drugs. 2006;6(5):357-9. doi: 10.2165/00129784-200606050-00009.
3
Ranolazine: a review of its use in chronic stable angina pectoris.雷诺嗪：其在慢性稳定型心绞痛中应用的综述
Drugs. 2006;66(5):693-710. doi: 10.2165/00003495-200666050-00010.
4
Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study.在慢性稳定型心绞痛患者中，雷诺嗪作为主要联合用药美托洛尔的附加药物的抗心绞痛疗效和耐受性：一项前瞻性、开放标签研究。
J Pharmacol Pharmacother. 2017 Jan-Mar;8(1):21-27. doi: 10.4103/jpp.JPP_168_16.
5
Ranolazine, a new antianginal drug.雷诺嗪，一种新型抗心绞痛药物。
Future Cardiol. 2005 Jul;1(4):447-55. doi: 10.2217/14796678.1.4.447.
6
At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine.在治疗心绞痛的新时代曙光中，还是仅仅是另一种抗心绞痛药物？关于雷诺嗪的一些思考。
Rom J Intern Med. 2010;48(4):361-9.
7
Ranolazine in patients with angina and coronary artery disease.患有心绞痛和冠状动脉疾病患者中的雷诺嗪
Curr Cardiol Rep. 2007 Jul;9(4):272-8. doi: 10.1007/BF02938375.
8
Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.雷诺嗪治疗合并心房颤动和间歇性左束支传导阻滞的女性稳定型心绞痛——病例报告
Pol Merkur Lekarski. 2016 Dec 22;41(246):287-292.
9
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.抗心绞痛药物雷诺嗪、尼可地尔和伊伐布雷定对非阻塞性冠状动脉疾病患者冠状动脉微血管功能的影响：一项随机对照试验的荟萃分析。
Clin Ther. 2019 Oct;41(10):2137-2152.e12. doi: 10.1016/j.clinthera.2019.08.008. Epub 2019 Sep 21.
10
Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.慢性稳定性心绞痛退伍军人中雷诺嗪与常规抗心绞痛药物使用者的临床和经济结局。
Am J Cardiol. 2018 Dec 1;122(11):1809-1816. doi: 10.1016/j.amjcard.2018.08.027. Epub 2018 Sep 8.

引用本文的文献

1
EASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024.易与否。欧亚六国关于近期指南的年度共识：动脉高血压、心房颤动、慢性冠状动脉综合征和外周动脉疾病。这些患者的新型或传统治疗选择。2024年立场文件
Cardiol J. 2025;32(3):213-227. doi: 10.5603/cj.105140. Epub 2025 May 13.
2
TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice.行动时机。意大利-西班牙-波兰-乌兹别克专家论坛立场文件 2022 年版。血脂异常和动脉高血压：临床实践中最重要且可改变的两个危险因素。
Cardiol J. 2022;29(5):730-738. doi: 10.5603/CJ.a2022.0087. Epub 2022 Sep 19.

本文引用的文献

1
Atrial fibrillation burden and the risk of stroke: A systematic review and dose-response meta-analysis.心房颤动负荷与中风风险：一项系统评价和剂量反应荟萃分析。
World J Clin Cases. 2022 Jan 21;10(3):939-953. doi: 10.12998/wjcc.v10.i3.939.
2
Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning.雷诺嗪：一种潜力初现的老药；临床前和临床研究对其可能重新定位的启示
Pharmaceuticals (Basel). 2021 Dec 25;15(1):31. doi: 10.3390/ph15010031.
3
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.
COVID-19住院患者中心房颤动的患病率及影响：一项系统评价和荟萃分析
J Clin Med. 2021 Jun 4;10(11):2490. doi: 10.3390/jcm10112490.
4
Role of Ranolazine in the Prevention and Treatment of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Clinical Trials.雷诺嗪在左心室收缩功能障碍患者心房颤动预防和治疗中的作用：一项随机临床试验的荟萃分析
Diseases. 2021 Apr 16;9(2):31. doi: 10.3390/diseases9020031.
5
"Ranolaziodarone"-A Synergism You Should Not Miss.“雷诺唑胺与胺碘酮联用”——一种不容错过的协同作用
J Innov Card Rhythm Manag. 2021 Mar 15;12(3):4429-4431. doi: 10.19102/icrm.2021.120303. eCollection 2021 Mar.
6
Meta-Analysis of Atrial Fibrillation in Patients With COVID-19.新型冠状病毒肺炎患者心房颤动的Meta分析
Am J Cardiol. 2021 Apr 1;144:152-156. doi: 10.1016/j.amjcard.2021.01.010. Epub 2021 Jan 27.
7
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.21 世纪心房颤动的流行病学：新方法与新见解。
Circ Res. 2020 Jun 19;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340. Epub 2020 Jun 18.
8
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.心房颤动的全球流行病学：日益严重的流行趋势及公共卫生挑战。
Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19.
9
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis.雷诺嗪用于心房颤动的节律控制：一项系统评价和荟萃分析。
Int J Cardiol. 2017 Jan 15;227:284-291. doi: 10.1016/j.ijcard.2016.11.103. Epub 2016 Nov 9.
10
Role of ranolazine in the prevention and treatment of atrial fibrillation: A meta-analysis of randomized clinical trials.雷诺嗪在心房颤动预防和治疗中的作用：随机临床试验的荟萃分析。
Heart Rhythm. 2017 Jan;14(1):3-11. doi: 10.1016/j.hrthm.2016.10.008. Epub 2016 Oct 13.